GSPT1 and acute myeloid leukemia: Matyskiela et al. reported that targeted degradation of GSPT1 through the CC-885-mediated interbridge between GSPT1 and the CRL4CRBN ubiquitin ligase complex shows broad antitumor activity in both cell lines and patient samples of acute myeloid leukemia [9].